This enrichment in seminomas is consistent with mutation of KIT and its downstream effectors occurring at an early stage of TGC tumorigenesis and blocking differentiation from the inherently platinum-sensitive PGC-like seminomatous state10. The gene discussed is KIT; the disease is seminoma.